Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ETTEPLAN Q3 2019: Profitable growth accelerated

Etteplan Oyj Interim Report October 31, 2019, at 1:00 p.m. ETTEPLAN Q3 2019: Profitable growth accelerated Review period July-September 2019        ·  The Group’s revenue grew by 17.0 per cent and was EUR 61.5 million (7-9/2018: EUR 52.6 million). At comparable exchange rates, growth was 17.6 per cent. ·  Organic growth was 5.1 per cent. At comparable exchange rates, organic growth was 5.8 per cent. ·  Operating profit (EBITA) improved and amounted to EUR 6.6 (5.0) million or 10.7 (9.6) per cent of revenue. ·  Operating profit (EBIT) was EUR 5.7 (4.4) million or 9.3 (8.3)

Scandi Standard – Third quarter presentation

Scandi Standard will publish its report for the third quarter 2019 on Wednesday, 6 November 2019 at 07.30 CET. Conference call at 08.3o CETThe Company will host a conference call for the financial community at 08.30 CET the same day.The conference call will be hosted by Leif Bergvall Hansen, CEO and Julia Lagerqvist, CFO. Dial in numbers: Sweden: 010 884 80 16UK: 020 3936 2999US: 1 646 664 1960All other locations: +44 20 3936 2999 Participant Access Code: 036109 The presentation used in the conference call will be published at http://www.scandistandard.com  

Xspray receives FDA clearance of IND for HyNap-Dasa

2019.10.31 STOCKHOLM – October 31, 2019. Xspray Pharma (Nasdaq First North Growth Market: XSPRAY) announces that the US Food and Drug Administration (FDA) has cleared the company's IND application for the product candidate HyNap-Dasa.Xspray Pharma's Investigational New Drug (IND) application, for permission to produce materials for and conduct clinical trials with the product candidate HyNap-Dasa, was accepted for review on September 30, 2019 by the US FDA. The application has now been given clearance by the FDA's Division of Hematology Products (DHP). “We are very pleased that the

Resolutions at the Extraordinary General Meeting in Midsona on 31 October 2019

The information contained in this press release is not intended, and may not, directly or indirectly, wholly or partly, be distributed, published or disseminated in or to australia,hong kong, japan, canada, new zeAland, switzerland, singapore, south africa, the united states of america or any other jurisdiction in which such action may violate local Securities Law or other regulations of said jurisdiction. See the section “Important information” at the end of this press release for further information.Today’s Extraordinary General Meeting in Midsona AB (publ) (“Midsona” or the “Company”)

Company Announcement No. 107, 2019 – Debtor composition in Nordea Kredit (CK 92)

Monthly information on debtor composition in Nordea Kredit published in order to comply with the Transparency Directive's disclosure requirements.Nordea Kredit hereby publishes monthly data on debtor composition of all callable bond series. The information is subject to disclosure requirements in the Securities Trading Act § 27a section 1.The information is also published in the usual way via the Copenhagen Stock Exchange / OMX.     Nordea Kredit Realkreditaktieselskab    Bo Dam Klausen Phone : +45 55 47 31 42

Euroresearch's and Zoono's products are now in Drugsson's warehouse

Double Bond Pharmaceutical's subsidiary Drugsson AB, distributor of Biopad, Biospray and a number of Biocide products (from Zoono) in the Nordic market, has received its deliveries of all products to Sweden. The products will be stored in stock. Biopad, Biospray is manufactured in Italy. The biocidal products are manufactured in New Zealand and imported via the UK. These are under registration in Sweden and will be available for the Swedish market shortly. “We are pleased that the products will be on sale shortly,” comments by Igor Lokot, CEO of Double Bond Pharmaceutical and Drugsson AB,

PSV contract awarded by Wintershall DEA

Wintershall DEA in Norway have awarded Solstad Offshore ASA a medium-term contract to support their operations in Norway. The award is a call off from an established frame agreement. Commencement of the contract will take place during Q4 2019, estimated duration is 120-200 days and it will be covered by the large PSV Normand Skude. Skudeneshavn, October 31st, 2019 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Anders Hall Jomaas CFO, at +47 40 04 29 18 Solstad Offshore ASAwww.solstad.com This information is subject of the disclosure requirements according to the

Altor and Stordalen new owners of Vinggruppen

Yesterday, the new ownership trio of the Ving Group was presented, it consists of Altor Fund V (Altor), Strawberry Group, controlled by Petter Stordalen and TDR Capital. The ownership group ensures a strong and long-term Nordic majority ownership of the Nordic business, consisting of 2,300 employees. Early Thursday morning, the deal could be formally closed, which means that, as of today, the new Nordic Leisure Travel Group, formed by the owners, owns Ving, Spies, Tjäreborg and the Nordic airline, which has now changed its name to Sunclass Airlines.“It is a fantastic business that ended up

Conversion of shares in Skanska AB

In conjunction with a conversion of shares, the company is obliged, according to the Financial Instruments Trading Act (1991:980), to disclose information concerning the change.During October 2019, 3,040 Series A shares were converted to Series B shares at the request of shareholders. Accordingly, the total number of votes in the company totals 597,359,735. The total number of registered shares in the company amounts to 419,903,072, of which 19,717,407 are Series A shares, and 400,185,665 are Series B shares.

Ideagen secures software contract with New Zealand’s largest general aviation provider, Airwork Group

The project will provide operational improvements across the organisation, particularly in risk and safety reportingThe Airwork Group, New Zealand’s largest general aviation organisation, is working with software firm, Ideagen, in a project that will enhance safety management – particularly safety reporting. Ideagen’s Coruson is being rolled out to help modernise overall safety and risk management processes to replace a number of Airwork’s current systems. Coruson will be used by around 500 members of staff across New Zealand, Australia and around the world as a modern software

YIT sells apartments to Elite Alfred Berg´s real estate fund

YIT Corporation Investor News October 31, 2019, at 12:00 p.m.YIT and Elite Alfred Berg Rental Income non-UCITS Fund have signed an agreement on the sale of 120 apartments located in the Helsinki metropolitan area. The total value of the agreement is approximately EUR 28 million. The transaction will be recognised in the fourth quarter of the year. The majority of the apartments to be sold as rental apartments have already been completed, with the rest to be completed in the beginning of the year 2020. For further information, please contact:Antti Inkilä, Executive Vice President,

Metsä Group’s comparable operating result in January–September 2019 was EUR 418 million

Metsä Group Interim Report January– September 2019, 31 October 2019 at 12:00 noon EETJanuary–September 2019 (1–9/2018) · Sales were EUR 4,183 million (4,290). · Operating result was EUR 342 million (635). Comparable operating result was EUR 418 million (641). · Result before tax was EUR 298 million (576). Comparable result before tax was EUR 374 million (582). · Cash flow from operations was EUR 421 million (591). July–September 2019 (7–9/2018) · Sales were EUR 1,374 million (1,386). · Operating result was EUR 110 million (223). Comparable operating result was EUR

Metsä Board’s comparable operating result in January–September 2019 was EUR 145 million

Metsä Board Corporation Interim Report 1 January–30 September 2019 31 October 2019 at 12:00 noon EETJanuary–September 2019 (1–9/2018) • Sales were EUR 1,453.4 million (1,486.1). • Comparable operating result was EUR 145.3 million (191.9), or 10.0% (12.9%) of sales. Operating result was EUR 160.8 million (186.3). • Comparable earnings per share were EUR 0.32 (0.44), and earnings per share were EUR 0.36 (0.43). • Comparable return on capital employed was 11.0% (14.7%). July–September 2019 (4–6/2019) • Sales were EUR 489.2 million (477.1). • Comparable operating result was

Nokian Tyres chooses iLOQ S10 digital locking system for the up coming testing center in Spain

Nokian Tyres’ new testing center in Spain enables year-round testing of summer, all-season and winter tires and the tracks will be ready in 2020. The total investment is estimated to be EUR 60 million. For the digital locking system, Nokian Tyres has chosen to partner with iLOQ. iLOQ is a Finnish company whose innovative technology and software is used to create self-powered digital locking and mobile access management solutions. With a focus on enhancing safety while reducing costs and conserving natural resources, in 2019 alone, iLOQ’s solutions will eliminate 27,000 kg of

Realfiction announces the positive outcome of a novelty search regarding the patent pending ECHO technology

The Danish Patent and Trademark Office and Budde Schou, Patent Attorneys have carried out novelty searches as part of the patentability investigation of the invention behind the ECHO technology and conclude that Realfiction’s directional pixel technology is novel with respect to the known techniques identified by the Danish Patent and Trademark Office Examiner and presents distinct advantages.It is common practice that the European patent authorities carry out a patentability investigation through research into existing technology that culminates in a written opinion regarding the

OmniCar Holding AB: Claus T. Hansen CEO of Omnicar Holding increase his share holdings with 200.000 shares

Claus T. Hansen CEO of Omnicar Holding AB have acquired 200.000 shares in Omnicar Holding AB on the 30th October 2019 Claus T. Hansen says “as previous annonced on 19th of September 2019 I am currently increasing my holdings. My total purchase of shares during Q3 are now 400.000 shares. I expect to increase my shareholding further during Q4.  For more information about OmniCar Holding AB, please contact: Claus T. Hansen, CEO OmniCar Holding AB E-mail: cth@omnicar.dk

Interim report 3 2019 Invent Medic Sweden AB

CEO Karin Bryder summarizes the quarterDuring the third quarter of 2019, we have spent alot of time on preparing the launches of efemia inthe UK and Germany which are taking place nowin the fourth quarter. Among other things, we havedelivered the first product orders. At the same time,we continue our marketing of efemia in Sweden,where several regions in the healthcare sector finallyinitiated relevant procurement processes in whichwe participate with efemia. During the quarter, wealso participated in the International ContinenceSociety’s (ICS) annual meeting in Gothenburg.There was a great

Transcendent Group launches a new service within RegTech

Transcendent Group launches the first version of an add-on module for its digital service Regulatory Framework Application (RFA) – RFA Monitor, a tool that facilitates for the user to stay up-to-date on new and updated regulations.RFA is a digital service where the internal regulatory framework can be developed, decided on, administrated and updated. ”In practice, RFA means that our customers can focus on application and implementation, instead of spending time on administration and updates. Our new add-on module RFA is an easy tool for keeping up with all regulatory changes coming from

Summons to bondholders’ meetings

Bonheur ASA has called for bondholders' meetings for the bond issues "BON06" (ISIN NO0010714538), "BON07" (ISIN NO0010793565) and "BON08" (ISIN NO0010809577) to harmonize the equity ratio definition with the newly issued BON 09 (ISIN NO0010861313). The bondholders’ meetings will be held on 14 November 2019 at 13:00. Please see the attachment for further information. For questions, please contact: Bonheur ASA Øyvind B. Kristiansen, Fred. Olsen & Co., +47 90 01 05 29 or oyvind.kristiansen@fredolsen.com Haakon Magne Ore, Fred. Olsen & Co., +47 92 02 75 10 or hmore@fredolsen.com

Number of shares and votes in Medicover

The number of votes in Medicover AB (publ) (“Medicover ”) has changed as a result of conversions of in total 5,065 class A shares into class B shares carried out in October following requests from shareholders in accordance with the conversion clause in Medicover’s articles of association. Today, the last trading day of the month, there are in total 135,735,195 shares in Medicover, of which 78,796,431 are class A shares, together carrying 78,796,431 votes, 54,538,764 are class B shares, together carrying 5,453,876.4 votes and 2,400,000 are class C shares,

Managers’ transactions

Nordea Bank Abp – Stock exchange release – Managers’ transactions Transaction notification under Article 19 of the EU Market Abuse Regulation Person subject to the notification requirementName: Steen, BirgerPosition: Member of the Board of DirectorsIssuer: Nordea Bank AbpLEI: 529900ODI3047E2LIV03 Notification type: Initial NotificationReference number: 529900ODI3047E2LIV03_20191029152403_2 Transaction date: 2019-10-29Venue: OFF-EXCHANGE TRANSACTIONS (XOFF)Instrument type: SHAREISIN: FI4000297767Nature of the transaction: Acquisition    Transaction details

Invitation to Alfa Laval’s Capital Markets Day, December 5

Alfa Laval invites analysts, professional investors and media to its Capital Markets Day, which will be held on December 5 at Malmö Arena Hotel, Hyllie Boulevard 12, Malmö, Sweden. It will start at 11:00 CET and end at approximately 16:00 CET. For those of you arriving to Copenhagen Airport, we will offer a shuttle from the airport to Malmö Arena Hotel, just a 15 minutes ride to the other side of the bridge between Denmark and Sweden. The first part will include presentations by Jan Allde, CFO and Mikael Tydén, Head of Operations. This contains an update on the larger investment programs

Nomination Committee for Duni’s AGM 2020

Pursuant to a resolution adopted at Duni’s Annual General Meeting in 2019, a Nomination Committee has been appointed prior to the Annual General Meeting in 2020. Duni hereby announces the composition of the Nomination Committee.The following persons will serve on the Nomination Committee, which is charged with presenting proposals to the Annual General Meeting in 2020 regarding the composition of Duni’s Board of Directors, etc.: Mr Johan Andersson, Mellby Gård Investerings ABMr John Strömgren, Carnegie fonderMr Bernard R. Horn, Jr., Polaris Capital Management, LLCMr Magnus Yngen,

There are no items matching the current filter
There are no more items matching the current filter
Back to top